Expansion of DST will require strengthening of laboratory capacity, the introduction
of new rapid diagnostics, and improved reporting
from diagnostic centres. The increasing recognition of
XDR-TB in the world (Figure 16) reflects the increased
risk of acquisition of additional drug resistance or the
increased transmissibility of resistant strains of TB
when care and prevention are inadequate.